EEG-MRI test of methylphenidate in adult attention symptoms
Part of Mental health clinical trials.
This Phase 3 study tests how methylphenidate affects brain signals and attention in adults with ADHD, and in adults with mood-related attention problems. It also includes healthy volunteers to compare brain responses during brain scanning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old
- You have the ability to understand the study and sign consent
- If you can become pregnant, you must use effective birth control and have a negative pregnancy test before MRI, and agree not to get pregnant during the study
- You can safely take part in MRI and EEG (no non-removable metal/implants/pacemaker/unsafe devices)
- You do not have medical conditions that make methylphenidate unsafe (for example certain heart or blood vessel problems, glaucoma, or uncontrolled thyroid overactivity)
- You do not have certain mental health conditions that could affect safety (for example psychosis, severe untreated mood instability, or past severe bipolar episodes)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain imaging (MRI) to see how methylphenidate affects brain activity in people with ADHD. It may help doctors better understand how this medicine works and who benefits most.
This Phase 4 study checks whether certain markers change in the brain/body when children with ADHD take methylphenidate (a stimulant). It also compares these markers with healthy children to better understand ADHD.
This study uses brain scans (EEG) to understand which children with ADHD will respond well to stimulant medications. The goal is to help doctors choose the right treatment faster by looking at brain activity patterns before starting medication.
This trial tests whether methylphenidate (a stimulant medicine) helps adults with attention-deficit/hyperactivity disorder (ADHD). It is checking safety and effectiveness for people who can take the immediate-release form of the medicine.
This study looks at how the brain's electrical activity may predict whether a child with ADHD will respond well to methylphenidate (Ritalin). It aims to find biological markers that could help doctors choose the right treatment sooner.
This study tests if the medication methylphenidate (commonly used for ADHD) can help manage attention and behavior problems in people with KBG syndrome. Each person acts as their own test case to see if the drug works for them.
Hear when a new Adult ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.